Cargando…

Novel Prognostic Index of High-Risk Prostate Cancer Using Simple Summation of Very High-Risk Factors

SIMPLE SUMMARY: We explored the role of each very high-risk factor and found that simple summation of the number of very high-risk (VHR) factors (T3b–4 and Gleason score 9–10) is an easy and very high predictive power to separate VHR-2 (both T3b–4 and Gleason score 9–10) and others (VHR-1; T3b–4 or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamazaki, Hideya, Suzuki, Gen, Masui, Koji, Aibe, Norihiro, Shimizu, Daisuke, Kimoto, Takuya, Yamada, Kei, Shiraishi, Takumi, Fujihara, Atsuko, Okihara, Koji, Yoshida, Ken, Nakamura, Satoaki, Okabe, Haruumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306376/ https://www.ncbi.nlm.nih.gov/pubmed/34298697 http://dx.doi.org/10.3390/cancers13143486

Ejemplares similares

Role of Brachytherapy Boost in Clinically Localized Intermediate and High-Risk Prostate Cancer: Lack of Benefit in Patients with Very High-Risk Factors T3b–4 and/or Gleason 9–10
por: Yamazaki, Hideya, et al.
Publicado: (2022)

Radiotherapy for Clinically Localized T3b or T4 Very-High-Risk Prostate Cancer-Role of Dose Escalation Using High-Dose-Rate Brachytherapy Boost or High Dose Intensity Modulated Radiotherapy
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Radiotherapy for elder patients aged ≥80 with clinically localized prostate cancer – Brachytherapy enhanced late GU toxicity especially in elderly
por: Yamazaki, Hideya, et al.
Publicado: (2020)

Conventional dose versus dose escalated radiotherapy including high-dose-rate brachytherapy boost for patients with Gleason score 9–10 clinical localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2022)

High-dose-rate brachytherapy with external beam radiotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Ultrahypofractionated Radiotherapy versus Conventional to Moderate Hypofractionated Radiotherapy for Clinically Localized Prostate Cancer
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Effect of Androgen Deprivation Therapy on Other-Cause of Mortality in Elderly Patients with Clinically Localized Prostate Cancer Treated with Modern Radiotherapy: Is There a Negative Impact?
por: Yamazaki, Hideya, et al.
Publicado: (2019)

Comparison of Image-Guided Intensity-Modulated Radiotherapy and Low-dose Rate Brachytherapy with or without External Beam Radiotherapy in Patients with Localized Prostate Cancer
por: Tsubokura, Takuji, et al.
Publicado: (2018)

Author Correction: Comparison of Image-Guided Intensity-Modulated Radiotherapy and Low-dose Rate Brachytherapy with or without External Beam Radiotherapy in Patients with Localized Prostate Cancer
por: Tsubokura, Takuji, et al.
Publicado: (2018)

Comparison of toxicities between ultrahypofractionated radiotherapy versus brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2022)

Potential Risk of Other-Cause Mortality Due to Long-Term Androgen Deprivation Therapy in Elderly Patients with Clinically Localized Prostate Cancer Treated with Radiotherapy—A Confirmation Study
por: Yamazaki, Hideya, et al.
Publicado: (2020)

Potential risk of alpha-glucosidase inhibitor administration in prostate cancer external radiotherapy by exceptional rectal gas production: a case report
por: Nishimura, Takuya, et al.
Publicado: (2014)

Clinical outcome of patients treated with re-irradiation for spine or pelvic bone metastasis: A multi-institutional analysis of 98 patients
por: Suzuki, Gen, et al.
Publicado: (2017)

Radiotherapy for Elderly Patients Aged ≥75 Years with Clinically Localized Prostate Cancer—Is There a Role of Brachytherapy?
por: Yamazaki, Hideya, et al.
Publicado: (2018)

Outcome and toxicity of stereotactic body radiotherapy with helical tomotherapy for inoperable lung tumor: analysis of Grade 5 radiation pneumonitis
por: Aibe, Norihiro, et al.
Publicado: (2014)

Increasing rectum–prostate distance using a hydrogel spacer to reduce radiation exposure during proton beam therapy for prostate cancer
por: Narukawa, Tsukasa, et al.
Publicado: (2023)

Comparison of radiation dermatitis between hypofractionated and conventionally fractionated postoperative radiotherapy: objective, longitudinal assessment of skin color
por: Yamazaki, Hideya, et al.
Publicado: (2018)

The Feasibility of Omitting Postoperative Radiotherapy in Japanese Patients With Ductal Carcinoma In Situ of Breast Treated With Breast-Conserving Surgery
por: Nakashima, Akihiro, et al.
Publicado: (2023)

High-Dose-Rate Brachytherapy Monotherapy versus Image-Guided Intensity-Modulated Radiotherapy with Helical Tomotherapy for Patients with Localized Prostate Cancer
por: Yamazaki, Hideya, et al.
Publicado: (2018)

Small bowel perforation caused by applicator implantation in high-dose-rate interstitial brachytherapy for recurrent pelvic tumor: a case report
por: Masui, Koji, et al.
Publicado: (2020)

Clinical Usefulness of the Platelet-to Lymphocyte Ratio in Patients with Angiosarcoma of the Face and Scalp
por: Suzuki, Gen, et al.
Publicado: (2017)

Radiotherapy for T1N0M0 Esophageal Cancer: Analyses of the Predictive Factors and the Role of Endoscopic Submucosal Dissection in the Local Control
por: Suzuki, Gen, et al.
Publicado: (2018)

Abiraterone acetate versus bicalutamide in combination with gonadotropin releasing hormone antagonist therapy for high risk metastatic hormone sensitive prostate cancer
por: Ueda, Takashi, et al.
Publicado: (2021)

A surveillance study of patterns of reirradiation practice using external beam radiotherapy in Japan
por: Yamazaki, Hideya, et al.
Publicado: (2020)

＜Editors’ Choice＞ Elective nodal irradiation versus involved field radiotherapy for limited disease small cell lung cancer: a single-institution experience
por: Suzuki, Gen, et al.
Publicado: (2022)

Reirradiation for local recurrence of oral, pharyngeal, and laryngeal cancers: a multi-institutional study
por: Yamazaki, Hideya, et al.
Publicado: (2023)

Single-fraction image-guided high-dose-rate brachytherapy for head and neck cancer: three cases of palliative brachytherapy
por: Ota, Yoshiaki, et al.
Publicado: (2020)

Evaluation of dosimetry and excess seeds in permanent brachytherapy using a modified hybrid method: a single-institution experience
por: Kobayashi, Kana, et al.
Publicado: (2013)

Endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer: choice of new approach
por: Suzuki, Gen, et al.
Publicado: (2018)

Challenge and Outcome for the Prostate Squamous Cell Carcinoma Which Developed 8 Years after Low-Dose-Rate Brachytherapy Approached by a Combined Multimodal Treatment with High-Dose-Rate Interstitial Brachytherapy, External Beam Radiation Therapy, and Chemotherapy
por: Matsugasumi, Toru, et al.
Publicado: (2021)

Reirradiation for Nasal Cavity or Paranasal Sinus Tumor—A Multi-Institutional Study
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Chemoradiation versus surgery for superficial esophageal squamous cell carcinoma after noncurative endoscopic submucosal dissection: comparison of long-term oncologic outcomes
por: Suzuki, Gen, et al.
Publicado: (2022)

Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2020)

Reirradiation for Rare Head and Neck Cancers: Orbit, Auditory Organ, and Salivary Glands
por: Yamazaki, Hideya, et al.
Publicado: (2022)

Importance of Continuous Sequential Chemotherapy and Multimodal Treatment for Advanced Testicular Cancer: A High-Volume Japanese Center Experience
por: Nakamura, Terukazu, et al.
Publicado: (2015)

Measurement of exhaled nitric oxide and serum surfactant protein D levels for monitoring radiation pneumonitis following thoracic radiotherapy
por: Yamazaki, Hideya, et al.
Publicado: (2017)

Abscopal effect of high-dose-rate brachytherapy on pelvic bone metastases from renal cell carcinoma: a case report
por: Suzuki, Gen, et al.
Publicado: (2019)

Effective heart-sparing whole lung irradiation using volumetric modulated arc therapy: a case report
por: Suzuki, Gen, et al.
Publicado: (2019)

3D-Image-Guided Multi-Catheter Interstitial Brachytherapy for Bulky and High-Risk Stage IIB–IVB Cervical Cancer
por: Kokabu, Tetsuya, et al.
Publicado: (2022)

Role of vaginal pallor reaction in predicting late vaginal stenosis after high-dose-rate brachytherapy in treatment-naive patients with cervical cancer
por: Yoshida, Ken, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fe9tlhgqji40ghvufct7gdrb3f